Rankings
▼
Calendar
LIVN Q1 2024 Earnings — LivaNova PLC Revenue & Financial Results | Market Cap Arena
LIVN
LivaNova PLC
$3B
Q1 2024 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$295M
+12.0% YoY
Gross Profit
$207M
70.3% margin
Operating Income
$16M
5.5% margin
Net Income
-$42M
-14.2% margin
EPS (Diluted)
$-0.78
QoQ Revenue Growth
-4.9%
Cash Flow
Operating Cash Flow
$10M
Free Cash Flow
$4M
Stock-Based Comp.
$10M
Balance Sheet
Total Assets
$2.5B
Total Liabilities
$1.2B
Stockholders' Equity
$1.2B
Cash & Equivalents
$309M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$295M
$263M
+12.0%
Gross Profit
$207M
$174M
+19.1%
Operating Income
$16M
-$2M
+793.7%
Net Income
-$42M
$7M
-669.1%
Revenue Segments
Cardiopulmonary Segment
$156M
54%
Neuromodulation Segment
$134M
46%
Geographic Segments
UNITED STATES
$161M
54%
Locations Excluding The United States And Europe
$80M
27%
Europe
$54M
18%
← FY 2024
All Quarters
Q2 2024 →